Effect and safety of ripretinib in the treatment of advanced gastrointestinal stromal tumor: A systematic review and meta-analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-3)

Sum=50

Publishing Process of This Article

Item

Count

Browse

Download

Sum=2

Aug 24, 2024 (publication date) through Aug 17, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Clin Oncol. Aug 24, 2024; 15(8): 1092-1101
Published online Aug 24, 2024. doi: 10.5306/wjco.v15.i8.1092

Table 2 Quality assessment using the Jadad Scale for randomized controlled trial

RCT: Randomized controlled trial.

Citation: Li J, Zhang H, Chen XD. Effect and safety of ripretinib in the treatment of advanced gastrointestinal stromal tumor: A systematic review and meta-analysis. World J Clin Oncol 2024; 15(8): 1092-1101
URL: https://www.wjgnet.com/2218-4333/full/v15/i8/1092.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i8.1092